• Episode 46: Dr. Carsten Rudolph, CEO and Managing Director at Ethris

  • Dec 12 2024
  • Length: 37 mins
  • Podcast

Episode 46: Dr. Carsten Rudolph, CEO and Managing Director at Ethris

  • Summary

  • "It's really a very important challenge we had from the very beginning, to see how to stabilize nanoparticles with the messenger RNA so they are not destroyed during nebulization." - Dr. Carsten Rudolph, CEO and Managing Director at Ethris

    Welcome to the latest episode of Biorasi's Few & Far Between podcast. Join host Chris O'Brien and guest, Dr. Carsten Rudolph, as they discuss the current state and bright future of nasal vaccine technology.

    Tune in today!

    Show more Show less
activate_Holiday_promo_in_buybox_DT_T2

What listeners say about Episode 46: Dr. Carsten Rudolph, CEO and Managing Director at Ethris

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.